1051 related articles for article (PubMed ID: 16784653)
21. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor levels in liver and blood, and post-operative liver cell proliferation in patients with benign and malignant liver tumors after partial hepatectomy.
Dłuzniewska J; Zolich D; Polański J; Zajac L; Sitkiewicz D; Łukomska B
Med Sci Monit; 2002 Oct; 8(10):CR690-6. PubMed ID: 12388921
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors influencing postoperative survival in patients with Wu FS; Zhao WH; Liang TB; Ren GP; Ma ZM; Teng LS
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):579-83. PubMed ID: 15938929
[TBL] [Abstract][Full Text] [Related]
24. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
Vejchapipat P; Tangkijvanich P; Theamboonlers A; Chongsrisawat V; Chittmittrapap S; Poovorawan Y
J Gastroenterol; 2004 Dec; 39(12):1182-8. PubMed ID: 15622483
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
26. [Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].
Chen XJ; Wu LM; Xu XB; Feng XW; Xie HY; Zhang M; Shen Y; Wang WL; Liang TB; Zheng SS
Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1354-8. PubMed ID: 18241575
[TBL] [Abstract][Full Text] [Related]
27. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Jeng KS; Sheen IS; Tsai YC
Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma.
Osada S; Kanematsu M; Imai H; Goshima S; Sugiyama Y
J Am Coll Surg; 2005 Sep; 201(3):405-11. PubMed ID: 16125074
[TBL] [Abstract][Full Text] [Related]
30. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
[TBL] [Abstract][Full Text] [Related]
31. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
[TBL] [Abstract][Full Text] [Related]
32. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma.
Varnholt H; Asayama Y; Aishima S; Taguchi K; Sugimachi K; Tsuneyoshi M
Oncol Rep; 2002; 9(1):35-41. PubMed ID: 11748452
[TBL] [Abstract][Full Text] [Related]
33. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
Junbo H; Li Q; Zaide W; Yunde H
In Vivo; 1999; 13(2):177-80. PubMed ID: 10363175
[TBL] [Abstract][Full Text] [Related]
34. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
35. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
36. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.
Qian CN; Guo X; Cao B; Kort EJ; Lee CC; Chen J; Wang LM; Mai WY; Min HQ; Hong MH; Vande Woude GF; Resau JH; Teh BT
Cancer Res; 2002 Jan; 62(2):589-96. PubMed ID: 11809714
[TBL] [Abstract][Full Text] [Related]
37. Survival factors after resection of small hepatocellular carcinoma.
Wu FS; Zhao WH; Liang TB; Ma ZM; Teng LS; Wang M; Zheng SS
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):379-84. PubMed ID: 16109520
[TBL] [Abstract][Full Text] [Related]
38. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
40. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
